Kayothera, Inc. Raises $8 Million In Series A Financing Led By Accelerator Life Science Partners To Develop Novel Cancer Immunotherapeutics
Amount Raised
$8 Million
Round Type
Series A
PrincetonOtherBiotechnologyHealth CareTherapeuticsDescription
KayoThera, Inc. (“KayoThera”), an early-stage therapeutics company developing novel cancer immunotherapies, today announces the closing of an $8 million Series A round of financing. The financing was led by Accelerator Life Science Partners (“ALSP”) with participation from BioAdvance and 7G Bioventures. KayoThera will focus its therapeutic development efforts on its lead oncology program to further advance the technology towards a product that will benefit patients with late-stage and metastatic cancers.
Quick answer
KayoThera, Inc. raised $8 Million in a Series A round, dated March 16, 2022. KayoThera, Inc. is based in Princeton, West Virginia, United States.
- How much did KayoThera, Inc. raise?
- KayoThera, Inc. raised $8 Million in a Series A round on March 16, 2022.
- What does KayoThera, Inc. do?
- KayoThera, Inc. is an early-stage therapeutics company focused on the development of first-in-class, oral, small molecule inhibitors of the retinoid pathway.
- Where is KayoThera, Inc. based and how big is it?
- KayoThera, Inc. is based in Princeton, West Virginia, United States.
- Who are the decision-makers at KayoThera, Inc?
- Fundz holds 1 contact at KayoThera, Inc., including the Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as KayoThera, Inc. that raised within 45 days of this round, from Fundz verified event records.
- MitoRx Therapeutics raised an undisclosed amount (Seed) on April 25, 2022.
- CytoDyn raised $1.9M (Seed) on April 22, 2022.
- BioNTech raised $150M on April 14, 2022.
- Prilenia raised an undisclosed amount (Series B) on April 12, 2022.
- Theriva Biologics raised $1.5M (Seed) on March 21, 2022.
- MAIA Biotechnology raised $2.4M (Seed) on March 16, 2022.
Who to call at KayoThera, Inc., and when
A new round usually means KayoThera, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day KayoThera, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at KayoThera, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at KayoThera, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment KayoThera, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansKayoThera, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.